Tone mix
Week by week 51 weeks
Share of Precigen, Inc. Common Stock's 144 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Jul 14, 2025 · tone +100Precigen (NASDAQ:PGEN) Upgraded at Wall Street Zen+85
- Week of Nov 10, 2025 · tone 0Precigen (PGEN) Q3 2025 Earnings Call Transcript-78
- Week of Mar 16, 2026 · tone 0Boxer Capital Management LLC Buys New Position in Precigen, Inc. $PGEN-58
- Week of Feb 16, 2026 · tone 0Precigen, Inc. (NASDAQ:PGEN) Receives Average Recommendation of "Hold" from Analysts-57
- Week of Apr 14, 2025 · tone 0Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th-57
- Week of Jun 1, 2026 · tone +99Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years+56
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Precigen, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 1 | 0 |
| Last 30 sessions | 12 | +41 |
| Last 90 sessions | 34 | +26 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Monday, October 26, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletPrecigen, Inc. (NASDAQ:PGEN) Stock Has Consensus Target Price of $13.67 According to BrokeragesNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Precigen, Inc. (NASDAQ:PGEN) Stock Has Consensus Target Price of $13.67 According to Brokerages | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 14, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- bethesdamagazine.com · 1 outletFrom Bethesda Magazine: Germantown biotech Precigen develops treatments for rare diseasesNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| From Bethesda Magazine: Germantown biotech Precigen develops treatments for rare diseases | bethesdamagazine.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 13, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.insidermonkey.com · 1 outletPrecigen (PGEN): Commercial Launch Success Validates Early Capital Raise ThesisPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Precigen (PGEN): Commercial Launch Success Validates Early Capital Raise Thesis | www.insidermonkey.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 5, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.dailypolitical.com · 1 outletHead-To-Head Analysis: Precigen (NASDAQ:PGEN) vs. Arcturus Therapeutics (NASDAQ:ARCT)Neutral
- www.tickerreport.com · 1 outletArcturus Therapeutics (NASDAQ:ARCT) versus Precigen (NASDAQ:PGEN) Financial ContrastNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head-To-Head Analysis: Precigen (NASDAQ:PGEN) vs. Arcturus Therapeutics (NASDAQ:ARCT) | www.dailypolitical.com | 1 | Neutral |
| Arcturus Therapeutics (NASDAQ:ARCT) versus Precigen (NASDAQ:PGEN) Financial Contrast | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 1, 2026
2 headlines, average tone +49: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.rttnews.com · 1 outletBiotech Stocks At 52-Week Highs - PGEN, EXEL, TWST, HNGE, PBYIPositive
- www.themarketsdaily.com · 1 outletComparing TScan Therapeutics (NASDAQ:TCRX) & Precigen (NASDAQ:PGEN)Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Biotech Stocks At 52-Week Highs - PGEN, EXEL, TWST, HNGE, PBYI | www.rttnews.com | 1 | Positive |
| Comparing TScan Therapeutics (NASDAQ:TCRX) & Precigen (NASDAQ:PGEN) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Precigen, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.